Joint Radionuclide Therapy-Immunotherapy Approach Effective in Prostate Cancer Model
Joint radionuclide therapy and immunotherapy approach. The combination shows promising [...]
February 2021 – The Winter Newsletter is out!
Looking back at 2020 accomplishments, fundraising campaign, meeting the newcomers [...]
World Cancer Day 2021
Today, the Oncidium foundation unites its voice with the World [...]
Hopeful 2021!
This year has shown us more than ever the importance [...]
New Theranostic Approach reduces tumor volume and increases survival in NET’s study
Axis - Dec 16, 2020 According to new research published [...]
Another achievement to bring Radiotheranostics forward
300 hospitals registered on the Oncidium foundation Map! Another achievement [...]
NET Patient Testimonial, how PRRT saved Tom’s life
Tom is a composer, pianist, audio producer and neuroendocrine tumor patient. [...]
Diagnostic accuracy of F-18-PSMA-1007-PET/CT imaging for prostate carcinoma
J. Nucl. Me. 2020 Aug 17 18F-PSMA-1007-PET/CT reliably detects malignant [...]
IPET 2020 – all you need to know about Theranostics
Event: IPET 2020, Beyond the visible - International Conference on [...]
Radiopharmaceuticals Emerging as New Cancer Therapy
National cancer Institute. October 26, 2020 The last years have [...]